US Patent Issued to Biosense Webster (Israel) on Sept. 30 for "Automatically performing irreversible electroporation ablation during heart refractory period" (Israeli Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,426,944, issued on Sept. 30, was assigned to Biosense Webster (Israel) Ltd. (Yokneam, Israel).

"Automatically performing irreversible electroporation ablation during heart refractory period" was invented by Assaf Govari (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method includes inserting an ablation catheter into an ablation site in a patient heart. Multiple electrocardiogram (ECG) signals are acquired. A refractory period of the patient heart is detected based on the acquired ECG signals. The ablation site is ablated using the ablation catheter during the detected refractory period."

The patent was filed on July 28, 2020, under A...